Pls find enclosed Intimation w.r.t Participation in Investor Conference.

Ajanta Pharma Limited Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000 Road, Chakala, Andheri (E), E legal.info@ajantapharma.com Mumbai 400 093, India W www.ajantapharma.com 31st August 2026 BSE LIMITED National Stock Exchange of India, Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. Dalal Street, C/1, G Block, Bandra Kurla Complex, Mumbai – 400001 Bandra (East), Mumbai – 400 051 Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ Sub: Intimation of Schedule of Analyst / Institutional Investor Meeting Dear Sir / Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we provide below the schedule of Analyst/Institutional Investor Meeting with the Company: # Date of Conference Name Type of Meeting Place Conference 1 16th September Jefferies India Forum one on one Oberoi, New 2026 Delhi 2 28th September PL Capital Mid & Small Cap Trident, BKC 2026 Conference 2026 The schedule of the above-mentioned meetings is subject to change and the change may occur due to exigencies on either side. We hereby confirm that the discussion during these meetings will be strictly on the basis of already published information. Thanking You, Yours faithfully, GAURANG SHAH Sr. VP - Legal & Company Secretary Corporate Identity Number - L24230MH1979PLC022059